Medpace Holdings, Inc.

Symbol: MEDP

NASDAQ

399.2

USD

Market price today

  • 39.3992

    P/E Ratio

  • 0.0000

    PEG Ratio

  • 12.37B

    MRK Cap

  • 0.00%

    DIV Yield

Medpace Holdings, Inc. (MEDP) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.28%

Operating Profit Margin

0.18%

Net Profit Margin

0.16%

Return on Assets

0.17%

Return on Equity

0.60%

Return on Capital Employed

0.42%

Company general description and statistics

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO:Dr. August James Troendle M.D.
Full-time employees:5800
City:Cincinnati
Address:5375 Medpace Way
IPO:2016-08-11
CIK:0001668397

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.

General Outlook

When we look at how much money they make before expenses, they keep 0.280% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.181%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.159%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.174% return, is a testament to Medpace Holdings, Inc.'s adeptness in optimizing resource deployment. Medpace Holdings, Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.597%. Furthermore, the proficiency of Medpace Holdings, Inc. in capital utilization is underscored by a remarkable 0.423% return on capital employed.

Stock Prices

Medpace Holdings, Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $403.62, while its low point bottomed out at $386.42. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Medpace Holdings, Inc.'s stock market.

Liquidity Ratios

Analyzing MEDP liquidity ratios reveals its financial health of the firm. The current ratio of 77.87% gauges short-term asset coverage for liabilities. The quick ratio (71.73%) assesses immediate liquidity, while the cash ratio (42.55%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio77.87%
Quick Ratio71.73%
Cash Ratio42.55%

Profitability Ratios

MEDP profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 18.47% underscores its earnings before tax deductions. The effective tax rate stands at 13.78%, revealing its tax efficiency. The net income per EBT, 86.22%, and the EBT per EBIT, 102.18%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 18.07%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin18.47%
Effective Tax Rate13.78%
Net Income per EBT86.22%
EBT per EBIT102.18%
EBIT per Revenue18.07%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 0.78, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations.

cards.indicatorcards.value
Days of Sales Outstanding72
Operating Cycle51.91
Days of Payables Outstanding6
Cash Conversion Cycle46
Receivables Turnover7.03
Payables Turnover57.92
Fixed Asset Turnover7.63
Asset Turnover1.09

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 16.40, and free cash flow per share, 15.35, depict cash generation on a per-share basis. The cash per share value, 13.20, showcases liquidity position. Lastly, the operating cash flow sales ratio, 0.26, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share16.40
Free Cash Flow per Share15.35
Cash per Share13.20
Operating Cash Flow Sales Ratio0.26
Free Cash Flow to Operating Cash Flow Ratio0.94
Cash Flow Coverage Ratio1.24
Short Term Coverage Ratio1.86
Capital Expenditure Coverage Ratio15.51
Dividend Paid and Capex Coverage Ratio15.51

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 22.75%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.61, we discern the balance between debt and equity financing. The long-term debt to capitalization, 16.86%, and total debt to capitalization, 37.82%, ratios shed light on its capital structure. An interest coverage of 47.71 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio22.75%
Debt Equity Ratio0.61
Long Term Debt to Capitalization16.86%
Total Debt to Capitalization37.82%
Interest Coverage47.71
Cash Flow to Debt Ratio1.24
Company Equity Multiplier2.67

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 61.38, provides a glimpse into top-line earnings distributed across each share. Net income per share, 9.21, reflects the portion of profit attributed to each share. The book value per share, 18.19, represents the net asset value distributed per share, while the tangible book value per share, -4.53, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share61.38
Net Income Per Share9.21
Book Value Per Share18.19
Tangible Book Value Per Share-4.53
Shareholders Equity Per Share18.19
Interest Debt Per Share14.15
Capex Per Share-1.19

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 29.17%, indicates top-line expansion, while the gross profit growth, 21.29%, reveals profitability trends. EBIT growth, 20.86%, and operating income growth, 20.86%, offer insights into operational profitability progression. The net income growth, 15.26%, showcases bottom-line expansion, and the EPS growth, 21.53%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth29.17%
Gross Profit Growth21.29%
EBIT Growth20.86%
Operating Income Growth20.86%
Net Income Growth15.26%
EPS Growth21.53%
EPS Diluted Growth21.98%
Weighted Average Shares Growth-5.14%
Weighted Average Shares Diluted Growth-5.43%
Operating Cash Flow Growth11.68%
Free Cash Flow Growth12.97%
10-Year Revenue Growth per Share762.56%
5-Year Revenue Growth per Share209.69%
3-Year Revenue Growth per Share136.24%
10-Year Operating CF Growth per Share451.16%
5-Year Operating CF Growth per Share220.24%
3-Year Operating CF Growth per Share94.33%
10-Year Net Income Growth per Share1320.84%
5-Year Net Income Growth per Share347.12%
3-Year Net Income Growth per Share125.63%
5-Year Shareholders Equity Growth per Share9.67%
3-Year Shareholders Equity Growth per Share-19.54%
Receivables Growth17.76%
Asset Growth22.50%
Book Value per Share Growth52.51%
Debt Growth-24.75%
SGA Expenses Growth22.79%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 9,313,887,660, captures the company's total value, considering both debt and equity. Income quality, 1.53, assesses the reliability of reported earnings. The ratio of intangibles to total assets, 42.14%, indicates the value of non-physical assets, and capex to operating cash flow, -8.46%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value9,313,887,660
Income Quality1.53
Sales General and Administrative to Revenue0.08
Intangibles to Total Assets42.14%
Capex to Operating Cash Flow-8.46%
Capex to Revenue-1.94%
Capex to Depreciation-139.20%
Stock-Based Compensation to Revenue1.09%
Graham Number61.39
Return on Tangible Assets29.50%
Graham Net Net-20.46
Working Capital-331,303,000
Tangible Asset Value-139,255,000
Net Current Asset Value-504,050,000
Invested Capital1
Average Receivables275,902,000
Average Payables32,469,000
Average Inventory0.5
Days Sales Outstanding58
Days Payables Outstanding9
ROIC28.55%
ROE0.51%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 18.33, and the price to book ratio, 18.33, reflect the market's valuation relative to the company's book value. The price to sales ratio, 6.30, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 26.13, and price to operating cash flows, 24.33, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio18.33
Price to Book Ratio18.33
Price to Sales Ratio6.30
Price Cash Flow Ratio24.33
Enterprise Value Multiple33.14
Price Fair Value18.33
Price to Operating Cash Flow Ratio24.33
Price to Free Cash Flows Ratio26.13
Price to Tangible Book Ratio16.85
Enterprise Value to Sales4.94
Enterprise Value Over EBITDA25.51
EV to Operating Cash Flow21.49
Earnings Yield3.00%
Free Cash Flow Yield4.21%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Medpace Holdings, Inc. (MEDP) on the NASDAQ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 39.399 in 2024.

What is the ticker symbol of Medpace Holdings, Inc. stock?

The ticker symbol of Medpace Holdings, Inc. stock is MEDP.

What is company IPO date?

IPO date of Medpace Holdings, Inc. is 2016-08-11.

What is company current share price?

Current share price is 399.200 USD.

What is stock market cap today?

The market cap of stock today is 12368573280.000.

What is PEG ratio in 2024?

The current 0.000 is 0.000 in 2024.

What is the number of employees in 2024?

In 2024 the company has 5800.